Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran in pediatric primary fibromyalgia
NCT01328002Phase 2Terminated
- Sponsor
- Forest Laboratories
- Start
- Apr 2011
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milnacipran in fibromyalgia (FM), sponsored by Forest Laboratories. Started Apr 2011; status: terminated.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01328002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01328002.